Close Menu

At the Medical Writing, Editing & Grantsmanship blog, this post notes the rising estimates of Challenge Grant applications. "Although the dust has not settled as yet, the NIH has currently accepted more than 18K RC1 applications, with another 11K in the error correction queue," according to the blogger. "CSR expects to engage 10K - 15K reviewers" -- which explains why you've probably gotten more than a few invitations already.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.